Home
Who We Are
About Us
Our Leadership
What Our Staff Has to Say
Career Opportunities
What We Do
Our Tools
Disease Area Strategy
Early R&D
Late Stage Development
How It Works
Our Insights
Recent
Oncology
Chronic Disease
R&D
Contact Us

Equinox Group

Home
Who We Are
About Us
Our Leadership
What Our Staff Has to Say
Career Opportunities
What We Do
Our Tools
Disease Area Strategy
Early R&D
Late Stage Development
How It Works
Our Insights
Recent
Oncology
Chronic Disease
R&D
Contact Us
unsplash-image-xuTJZ7uD7PI.jpg

R&D Insights

  • Our Insights
  • Recent
  • Oncology
  • Chronic Disease
  • R&D

 

Featured
Measuring Risk in R&D
Dec 29, 2025
R&D Insights
Measuring Risk in R&D
Dec 29, 2025
R&D Insights
Dec 29, 2025
R&D Insights
How Equinox Group Models Drugs in R&D: The Case of Alecensa in 1L ALK+ NSCLC
Nov 11, 2025
Oncology, R&D Insights
How Equinox Group Models Drugs in R&D: The Case of Alecensa in 1L ALK+ NSCLC
Nov 11, 2025
Oncology, R&D Insights
Nov 11, 2025
Oncology, R&D Insights
Screenshot 2025-10-30 154345.png
Oct 30, 2025
Oncology, R&D Insights
What indications should we focus on?
Oct 30, 2025
Oncology, R&D Insights
Oct 30, 2025
Oncology, R&D Insights
Two indications.PNG
Aug 26, 2020
Oncology, R&D Insights
Comparing Opportunity Across Subpopulations: Rozlytrek as a Case Study
Aug 26, 2020
Oncology, R&D Insights
Aug 26, 2020
Oncology, R&D Insights
Screenshot 2025-09-19 094758.png
Apr 2, 2020
Oncology, R&D Insights
Finding the Right Price for a Drug across Multiple Indications; Learnings from Keytruda
Apr 2, 2020
Oncology, R&D Insights
Apr 2, 2020
Oncology, R&D Insights
dfsdf.png
Jun 5, 2019
Oncology, R&D Insights
How to Price an Oncology Drug
Jun 5, 2019
Oncology, R&D Insights
Jun 5, 2019
Oncology, R&D Insights
Back to Top
 

Home

Our Tools

Privacy Policy

What We Do

How It Works

Contact Us